LYZ and Cirrhosis: The results of a previous study confirmed that patients with cirrhosis have an impaired oral defence system and a high level of inflammation, with significantly higher than normal levels of interleukin (IL)-6/IL-1β, and secretory IgA and lower than normal levels of lysozyme and histatins 1 and 522.